In today’s episode of the podcast, we are joined by psychiatrist and neuropharmacologist Dr. Ken Gillman who is the founder and convener of the International MAOI (monoamine oxidase inhibitor) Expert Group and widely recognized as a world expert in serotonin toxicity.
Serotonin toxicity (syndrome) is a rare as well as potentially lethal form of toxicity that results from excess serotonin within neuronal synapses. There are numerous poorly written/controlled case reports that have perpetuated misinformation about drugs that can cause serotonin toxicity. While the word “syndrome” is often used, toxicity is a more accurate description given that toxicity represents a spectrum of severity rather than a defined set of symptoms. In today’s podcast, we will discuss the pathophysiology, causes, clinical presentation, criteria, controversies, and medical management of serotonin toxicity.
Conflicts of interest for this episode: Dr. Gillman has equity interests in and is on the advisory board of NeuraWell Therapeutics, the company that has the patent for a modified form of tranylcypromine.
Full blog here: www.psychiatry...
Негізгі бет “Serotonin Toxicity”, Otherwise known as Serotonin Syndrome
Пікірлер: 13